Categories
News on Health & Science

Coming soon, the Hips and Knees that will Never Wear Out

[amazon_link asins=’0123983584,0124201458,0130416967,0128053615′ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’31e8dea1-5c85-11e7-86ff-13c98e6bc329′]

Replacement body parts that never wear out could become a reality within a few years as the  scientists say.

Dodgy knees and hips will be repaired using tissue engineering, while donor heart valves from animals are being specially treated to last indefinitely.
Longer-lasting artificial joints are already being tested in a bid to ensure people will be able to enjoy another 50 active years.

click & see
X-ray of female pelvix with total hips replacement

Scientists at the University of Leeds Institute of Medical and Biological Engineering have launched a £50million research initiative focused on areas of the body most affected by ageing, including joints, spine, teeth, heart and circulation.

Unlike studies involving stem cells and growing ‘spare parts’ in a lab, the programme uses the body’s own regenerative systems. The Leeds scientists have developed a chemical wash that strips cells away from donated cartilage, heart valves, blood vessels and other tissue before they are put into a human body.
Research shows they become repopulated with cells within about six months. Some 40 patients have already been treated with modified heart valves in a study in Brazil.

Professor John Fisher, director of the institute and one of the world’s leading researchers into artificial joints, said research so far had shown the valves did not deteriorate and were not rejected by the body, because ‘foreign’ donor cells had all been stripped away.
The unique method of removing living cells from human and animal tissue creates a biological ‘scaffold’ that can be regenerated within the body, at the site which needs repairing.

Worn-out ligaments and cartilage in knees can be replaced with a scaffold that will eventually attract cells to make the joint last longer.

Other areas targeted for treatment are the spine  –  where discs can be replaced  –  elbow and shoulder tissues and parts of the knee. Vascular patches are being devised that seal the holes made in arteries when surgeons clear a blockage.

The technique is not suitjointsable for whole organs, however. Professor Fisher has also designed a ceramic-on-metal hip joint that reduces ten-fold the wear and tear on artificial joints.

As a result people should be able to get spare parts at an earlier age, when they are less disabled, and they could last up to 50 years, he said.

The professor added: ‘Hip have been used for nearly 50 years but nowadays people want to cycle, play tennis, even go skiing, so they have to last longer.’
He said a scaffolding transplant would cost only around £1,000 a time. It was much more expensive to grow cells outside the body, and there was a higher infection risk.

Professor Eileen Ingham, deputy director of the Institute, said stem cells were not the answer to structural replacement of wornout bits of the body such as heart valves.

She said: ‘We are working with the NHS National Blood & Transplant Tissue Services to apply it to human donor valves. Once a patient has one, it should last a lifetime.’

Professor Christina Doyle, chief executive of Xeno Medical, predicted that in 20-30 years there would be techniques capable of regenerating human tissue off-the-shelf for use in operations.

She said: ‘It will be a case of the surgeon dialling up for spare parts to be delivered in a sterilised plastic bag.’

Source:Mail Online, 20th. Oct.’09

Reblog this post [with Zemanta]
Categories
News on Health & Science

Health Spreads Really do Lower Heart Risk

[amazon_link asins=’B0713V9NWJ,B009DGNRCU,B01EUZV5JA,B00FL1CLIC,B00X68XT2E,B00061MT0M,0471593427,B00C8TWVZI,B01LR478MK’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’c574d9a8-5c83-11e7-baaf-13bf9dbd18c1′]

The makers of two leading brands of spreads have been cleared to carry on claiming their products can reduce cholesterol.
Benecol and Flora pro.activ contain plant ingredients which EU health watchdogs now agree can help lower the risk of coronary heart disease….click & see

It is Britain’s biggest killer, with 110,000 victims a year.

Some two in three adults in Britain have raised cholesterol, which leads to clogged arteries and is a factor in heart disease.
The vital ingredients work with the body by partially blocking the entry of cholesterol into the bloodstream. It is claimed they lower bad cholesterol, known as LDL, by up to 15 per cent when used every day as part of a healthy diet and lifestyle.
Currently, millions of people rely on statin pills, prescribed by GPs, to reduce cholesterol. However, these can have side-effects, such as muscle pain.
Dietician and nutrition expert Helen Bond said: ‘People concerned about cholesterol need to have access to reliable, evidence based claims that will help them make wise food choices.

‘Dietary and lifestyle advice is always recommended as the first step for reducing cholesterol. Obesity, diabetes, raised cholesterol and a lack of physical activity are major risk factors for coronary heart disease.

‘This decision by the European Food Safety Authority will help people find the foods that will make a real difference.’
The manufacturers hailed the move to allow their so-called disease risk reduction claims as an important breakthrough.
Benecol products using the cholesterol reducing ingredients, called plant stanol esters, include drinks, yoghurts, spreads and cream cheese.
Benecol spokesman Esther van Onselen said: ‘Approval of the disease risk reduction claim is a really exciting step in helping consumers make an informed choice about which foods are proven to have a positive impact on their health.

‘There are more than 50 independent clinical studies which prove the cholesterol-lowering benefits of plant stanol esters.’
Flora pro.activ is made by Unilever, whose spokesman, Caroline Banquet, said: ‘We are delighted that the EU has now formally granted approval of our disease risk reduction claim.

‘Consumers can continue to be reassured that they can confidently trust our cholesterol-lowering health claims, in the knowledge that the science underpinning them has gone through rigorous and independent expert scrutiny.’
Unilever has carried out research into the cholesterol-lowering properties of plant ingredients since the 1980s. It first introduced Flora pro.activ spread in 2001, followed by yoghurt mini-drinks and milk drinks

Source:Mail Online, 23rd. Nov.’09

Reblog this post [with Zemanta]
Categories
News on Health & Science

New Way to ‘Stop’ Premature Birth

[amazon_link asins=’B00UNMS1OM,081292472X,B00A2AQYHG,B01BNGHCLE’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’191a3b2e-5c83-11e7-b7b0-f1d2c65d7c44′]

A drug used to treat cancer can stop contractions and may prevent premature labour, researchers say.
………click & see
The Newcastle University team tested the drug Trichostatin A on tissue taken from 36 women undergoing a caesarean.

The researchers said the therapy worked by increasing the levels of a protein that controls muscle relaxation.

One expert said with rates of premature births rising – there are 50,000 a year in the UK – a new treatment was badly needed.

Preterm labour and birth continue to be the single biggest cause of death in infants in the developed world and around 1,500 babies die in the UK every year.

A number of drugs are used to try to stop early labour, but most have serious side effects.

Trichostatin A (TSA) is known to promote the death of cancer cells.

The researchers got permission to take samples of the muscles of women undergoing caesarean sections at the Royal Victoria Infirmary in Newcastle, the Cellular and Molecular Medicine journal reported.

Contractions
They exposed the muscle to TSA and measured the effects on both spontaneous contractions and those induced by the labour drug, oxytocin.

They found an average 46% reduction in contractions for the spontaneously contracting tissue and an average 54% reduction in the oxytocin induced contractions.

It has been previously shown that a protein kinase A (PKA) is involved in controlling the relaxation of the uterus during pregnancy.

The researchers showed that TSA increased the levels of a protein sub-unit of PKA.

Professor Nick Europe-Finner, who led the research, said: “We will not give this drug to a patient because it can damage as many as 10% of the genes in a cell.

“But it does show us that other more specific agents that act on the same enzymes but only one at a time are worth investigating.”

New treatment
Dr Yolande Harley, deputy director of research at Action Medical Research which funded the study, said: “This project has uncovered some of the molecular pathways that regulate uterine contractions and so could be linked to premature birth.

“It could have a role in preventing premature birth – finding a new treatment for early labour would be a major step forward.”

Professor Jane Norman, a spokeswoman for the Royal College of Obstetrics and Gynaecology (RCOG), said: “At the moment, it’s not possible to treat preterm labour effectively. We only have drugs that delay it by 24 hours or so – not enough to deliver the baby safely.

“One of the interesting things about this research is that they are using a new kind of drug – the drugs we are currently using have been around for a long time.

“And they are targeting pathways we have not known about before.

“When you consider that preterm birth rates are rising in all four countries of the UK a new more effective drug is badly needed.”

Source:BBC News:Oct.22 ’09

Reblog this post [with Zemanta]
Categories
News on Health & Science

Anti-ageing Creams Could Cause Cancer

[amazon_link asins=’B00AMC3KIK,B00G0EJYFW,3587698961,7072968849,B0176L8IPY,B00WSPJ420,B012OQJWSI,B00KHY6JUY,B00WM0RGKS’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’8cfe015d-5c82-11e7-b696-175644068827′]

Anti-ageing creams, which promise to smooth away the fine lines of maturity, could lead to cancer by stripping the skin of its protective top  as explained by exparts.

A leading US professor has said that using these revolutionary creams could expose the skin to dangerous toxins and make it more prone to sun damage.

Dr Sam Epstein, chairman of the Cancer Prevention Coalition, has said that popular ingredients in anti-ageing creams called alpha-hydroxy acids (AHAs) were “probably the most dangerous cosmetic products on the market”.

And now, he has urged the American safety body to introduce new regulations to protect consumers and also asked British shoppers to be aware of the risks. “So many women, and even some men, slather these products all over their skin in the naive belief that they have nothing to fear but ageing,” The Daily Express quoted Epstein as saying.

The British cosmetics industry must comply with EU rules on what ingredients to use and what warnings to place on labels.

Currently, there is no requirement for a warning to be placed on creams containing AHAs.
However, Epstein pointed out that in America, the US Food and Drug Administration warned consumers that AHAs “could destroy the upper layers of skin, causing severe burns, swelling and pain”.

But he said that the dangers are equally relevant to British anti-wrinkle creams. “Anything that strips the surface of the skin not only risks sunlight penetrating the exposed layer but also allows other toxic products in. All of the toxic effects are massively increased by AHAs,” he said.

Epstein also expressed concern about other ingredients commonly used in anti-ageing products, such as limonene. “Apart from being an irritant, it is a well documented carcinogen,” he said.

Sources: The Times Of India

Reblog this post [with Zemanta]
Categories
News on Health & Science

Coffee Good for Chronic Hepatitis C Patients

Patients of chronic hepatitis C, who drink three or more cups of coffee daily, have a 53 percent lower risk of liver disease progression than non-coffee drinkers, says a new study
……….[amazon_link asins=’B013105UDM,B00CZA0MAQ,B00X6CKUW2,B01N4JBH3X,B01CF67U3G,B007TGDXNO,B00IHBM8J0,B00Q4IA7LY,B01N7K78GF’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’fe449997-5c7f-11e7-9753-61a378f1d184′]

The study, led by Neal Freedman of National Cancer Institute (NCI), found that patients with hepatitis C related cirrhosis who did not respond to treatment benefited from increased coffee intake. No effect on liver was observed in patients who drank black or green tea.

Hepatitis C virus (HCV) infects approximately 2.2 percent of the world’s population, including three million Americans. A centre for Disease Control and Prevention (CDC) cites HCV as the leading cause of liver transplantation in US, accounting for 8,000 to 10,000 deaths, annually.

The World Health Organisation (WHO) estimated that three to four million people contract HCV each year with 70 percent becoming chronic cases that can lead to cirrhosis of the liver and liver cancer.

This study included 766 participants enrolled in the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis (HALT-C) trial who had hepatitis C-related cirrhosis and failed to respond to standard treatment of the anti-viral drugs peginterferon and ribavirin, according to an NCI release.

Participants were seen every three months during the 3.8-year study period to assess clinical outcomes. Liver biopsies were also taken at 1.5 and 3.5 five years to determine the progression of liver disease.

“Results from our study suggest that patients with high coffee intake had a lower risk of disease progression,” said Freedman.

These findings will appear in the November issue of Hepatology

Sources: The Times Of India

Reblog this post [with Zemanta]
css.php